Targeted prodrug for treating castration-resistant prostate cancer as well as nano preparation and preparation method of targeted prodrug

A technology for castration resistance and prostate cancer, which is applied in the direction of antineoplastic drugs, pharmaceutical formulas, medical preparations of non-active ingredients, etc., can solve the problems of poor water solubility of CPT, and achieve the advantages of simple preparation method and excellent specific recognition effect Effect

Inactive Publication Date: 2015-12-23
SHANGHAI PUTUO DISTRICT CENT HOSPITAL
View PDF7 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] In order to solve the above-mentioned problems in the prior art, the inventor intends to covalently link CPT to polymers through esterase-sensitive β-thioester bonds, which can effectively overcome the problem of poor water solubility of CPT

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Targeted prodrug for treating castration-resistant prostate cancer as well as nano preparation and preparation method of targeted prodrug
  • Targeted prodrug for treating castration-resistant prostate cancer as well as nano preparation and preparation method of targeted prodrug
  • Targeted prodrug for treating castration-resistant prostate cancer as well as nano preparation and preparation method of targeted prodrug

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0045] In a second aspect, the present invention provides a method for preparing the above-mentioned targeted prodrug for treating castration-resistant prostate cancer, the synthetic route of the method is as follows: figure 1 As shown, it specifically includes the following steps:

[0046] (1) Preparation of intermediate product P(OEGMA-co-BSMA):

[0047] Add a certain amount of reversible addition-fragmentation chain transfer initiator trithioester BPTPA, oligoethylene glycol methacrylate OEGMA, monomer BSMA containing β-thiocarboxyl group, solvent and free radical initiator into the glass tube, Freeze and thaw three times in vacuum and seal the tube; then, react at 20-80°C for 0.5-40 hours to obtain the crude product P(OEGMA-co-BSMA); finally purify the crude product P(OEGMA-co-BSMA) Obtain the P(OEGMA-co-BSMA);

[0048] (2) Preparation of target product P(OEGMA-co-CPT-co-AR16):

[0049] Dissolve a certain amount of P(OEGMA-co-BSMA), N-hydroxysuccinimide, CPT, condensing...

Embodiment 1

[0071] AR16 peptide-modified poly(oligoethylene glycol methacrylate-co-camptothecin-co-AR16) macromolecular prodrug specifically targeting castration-resistant prostate cancer, namely P(OEGMA-co- CPT-co-AR16) preparation of targeted prodrug:

[0072] (1) Preparation of P(OEGMA-co-BSMA): A certain amount of BPTPA (33mg, 0.1mmol), OEGMA (2.70g, 9.0mmol), BSMA (218mg, 1.0mmol) and AIBN (1.6mg, 0.01mmol) Add to glass tube. Add 10 mL of dioxane, vacuum freeze-thaw three times, and then seal the tube. Thereafter, the reaction was carried out at 70° C. for 5 hours. The obtained reaction crude product was dialyzed in water for 24 hours to remove impurities, and freeze-dried. through 1 According to HNMR analysis, the degree of polymerization of P(OEGMA-co-BSMA) was 74, and the molar percentages of OEGMA and BSMA were 88% and 12%, respectively. Determined by GPC, P(OEGMA-co-BSMA) molecular weight M n =22,000, molecular weight distribution M w / M n = 1.02.

[0073] (2) Preparati...

Embodiment 2

[0075] Preparation of P(OEGMA-co-CPT-co-AR16) nano drug solution:

[0076] Dissolve 10 mg of P (OEGMA-co-CPT-co-AR16) in 1 mL of DMSO, drop the solution into 9 mL of stirred water, then put the solution into a dialysis bag (molecular weight cut-off of 7,000 Da) and dialyze for 24 hours to remove the organic solvent. That is, the nano drug solution is obtained. Its particle size is about 85.8nm (±1.56) (see Figure 4 ), potential -4.5mV (±0.18).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
Mwcoaaaaaaaaaa
Login to view more

Abstract

The invention provides a targeted prodrug for treating targeted prodrug for treating castration-resistant prostate cancer; the targeted prodrug is P (OEGMA-co-CPT-co-AR16), wherein POEGMA is a water-soluble polymer having a long circulation function, CPT is chemotherapeutic camptothecin having an antineoplastic activity and AR16 is polypeptide showing specific targeting to castration-resistant prostate cancer; the invention also provides a method for preparing the P (OEGMA-co-CPT-co-AR16), wherein the method, on the basis of a polymer P (OEGMA-co-BSMA) containing -thiocarboxyl, carries out esterification and ammonolysis reactions so as to modify CPT and AR16 on the polymer in a covalent mode, so that the targeted CPT macromolecular prodrug P (OEGMA-co-CPT-co-AR16) is obtained. In addition, the invention also provides a nano preparation and a preparation method of the targeted prodrug. The nano preparation of the targeted prodrug P (OEGMA-co-CPT-co-AR16) prepared by the method disclosed by the invention can be used for effectively killing cancer cells with a relatively low dosage, and can show an excellent specific recognition effect on castration-resistant prostate cancer.

Description

technical field [0001] The present invention relates to the technical field of tumor targeted delivery and sustained-release drug delivery system, in particular to a targeted prodrug for treating castration-resistant prostate cancer, a preparation method of the prodrug, and a nano-preparation of the prodrug and The preparation method of this nano preparation. Background technique [0002] Prostate cancer is the first and most common cancer in men worldwide, with 1.1 million newly diagnosed prostate cancer patients in 2012, accounting for about 15% of the total number of new cancer cases. In the past ten years, the incidence of prostate cancer in my country has shown a high incidence trend, and large cities have become the "hardest hit areas" for the incidence of prostate cancer. Prostate cancer is a hormone-dependent malignant tumor. Androgen plays an important role in the occurrence and development of prostate cancer. Castration (surgery or drugs) or combined androgen dep...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K47/48A61K31/4745A61K9/19A61P35/00
Inventor 殷佩浩刘涛袁易彭文袁夏贾婷婷邱艳艳邹瑜石晓静于卉
Owner SHANGHAI PUTUO DISTRICT CENT HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap